Aion Therapeutic Combines the Healing Powers of Cannabinoids and Psychedelics to Treat Cancer and Depression

To date, 74% of prescription drugs are derived from plants, 18% specifically from fungi. Still, many companies hesitate to invest in the medicinal benefits of mushrooms.

International pharmaceutical company Aion Therapeutic Inc. (CSE: AION) is taking the use of psychedelic mushrooms to the next level by combining them with cannabinoids. While some might call this a bold endeavor, evidence that these plants hold special healing properties has been present for centuries.

and Psychedelics as Medicine

Numerous cultures and societies including the Egyptians, Aztecs, Vikings, Greeks and Romans have used cannabis and mushroom plants for their natural healing powers. As far as history reveals, human use of these plants dates back to Neolithic human history.

Today, Aion Therapeutic seeks to move these practices forward by specializing in joining mushroom and cannabis compounds to create a new class of therapeutics to treat cancer, depression, viral infections, inflammation and other indications.

Mushrooms and cannabis have grown symbiotically in nature for millions of years, assisting in one another’s growth. Mushrooms help cannabis plants to absorb nutrients, while cannabis assists mushrooms in acquiring carbohydrates. With 2 plants already working together naturally, why …

Full story available on Benzinga.com

More Aion Therapeutic Combines the Healing Powers of Cannabinoids and Psychedelics to Treat Cancer and Depression